NCT07320105 2026-01-06Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)Fujian Cancer HospitalPhase 4 Recruiting60 enrolled
NCT06231680 2024-03-29Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)Henan Cancer HospitalPhase 2 Unknown132 enrolled
NCT05675033 2023-01-09Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung AdenocarcinomaFujian Cancer HospitalPhase 2 Unknown50 enrolled